My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 234

    1.

    Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma.

    Risérus U, Tan GD, Fielding BA, Neville MJ, Currie J, Savage DB, Chatterjee VK, Frayn KN, O'Rahilly S, Karpe F.

    Diabetes. 2005 May;54(5):1379-84.PMID: 15855323 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance.

    Sjögren P, Sierra-Johnson J, Gertow K, Rosell M, Vessby B, de Faire U, Hamsten A, Hellenius ML, Fisher RM.

    Diabetologia. 2008 Feb;51(2):328-35. Epub 2007 Nov 20.PMID: 18030445 [PubMed - indexed for MEDLINE]Related articles

    3.

    Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness.

    Yao-Borengasser A, Rassouli N, Varma V, Bodles AM, Rasouli N, Unal R, Phanavanh B, Ranganathan G, McGehee RE Jr, Kern PA.

    J Clin Endocrinol Metab. 2008 Nov;93(11):4431-9. Epub 2008 Aug 12.PMID: 18697866 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effects of pioglitazone on stearoyl-CoA desaturase in obese Zucker fa/fa rats.

    Toyama T, Kudo N, Hibino Y, Mitsumoto A, Nishikawa M, Kawashima Y.

    J Pharmacol Sci. 2007 Jun;104(2):137-45. Epub 2007 May 31.PMID: 17538229 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.

    Takasawa K, Kubota N, Terauchi Y, Kadowaki T.

    Endocr J. 2008 Aug;55(4):767-76. Epub 2008 May 28.PMID: 18506083 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.

    Chang CH, McNamara LA, Wu MS, Muise ES, Tan Y, Wood HB, Meinke PT, Thompson JR, Doebber TW, Berger JP, McCann ME.

    Eur J Pharmacol. 2008 Apr 14;584(1):192-201. Epub 2008 Feb 14.PMID: 18346728 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.

    Sutinen J, Kannisto K, Korsheninnikova E, Fisher RM, Ehrenborg E, Nyman T, Virkamäki A, Funahashi T, Matsuzawa Y, Vidal H, Hamsten A, Yki-Järvinen H.

    Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E941-9. Epub 2004 Jan 28.PMID: 14749206 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.

    Tiikkainen M, Häkkinen AM, Korsheninnikova E, Nyman T, Mäkimattila S, Yki-Järvinen H.

    Diabetes. 2004 Aug;53(8):2169-76.PMID: 15277403 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Desaturase activities in rat model of insulin resistance induced by a sucrose-rich diet.

    Brenner RR, Rimoldi OJ, Lombardo YB, González MS, Bernasconi AM, Chicco A, Basabe JC.

    Lipids. 2003 Jul;38(7):733-42.PMID: 14506836 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.

    Wake DJ, Stimson RH, Tan GD, Homer NZ, Andrew R, Karpe F, Walker BR.

    J Clin Endocrinol Metab. 2007 May;92(5):1848-56. Epub 2007 Feb 27.PMID: 17327378 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes.

    Kim H, Haluzik M, Gavrilova O, Yakar S, Portas J, Sun H, Pajvani UB, Scherer PE, LeRoith D.

    Diabetologia. 2004 Dec;47(12):2215-25. Epub 2004 Dec 15.PMID: 15662559 [PubMed - indexed for MEDLINE]Related articles

    12.

    Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.

    Kim HJ, Jung TW, Kang ES, Kim DJ, Ahn CW, Lee KW, Lee HC, Cha BS.

    Metabolism. 2007 May;56(5):676-85.PMID: 17445544 [PubMed - indexed for MEDLINE]Related articles

    13.

    PPAR-gamma response element activity in intact primary human adipocytes: effects of fatty acids.

    Sauma L, Stenkula KG, Kjølhede P, Strålfors P, Söderström M, Nystrom FH.

    Nutrition. 2006 Jan;22(1):60-8. Epub 2005 Oct 12.PMID: 16226011 [PubMed - indexed for MEDLINE]Related articles

    14.

    Rosiglitazone increases the expression of peroxisome proliferator-activated receptor-gamma target genes in adipose tissue, liver, and skeletal muscle in the sheep fetus in late gestation.

    Muhlhausler BS, Morrison JL, McMillen IC.

    Endocrinology. 2009 Sep;150(9):4287-94. Epub 2009 Jun 11.PMID: 19520784 [PubMed - indexed for MEDLINE]Related articles

    15.

    A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.

    Fujimura T, Kimura C, Oe T, Takata Y, Sakuma H, Aramori I, Mutoh S.

    J Pharmacol Exp Ther. 2006 Aug;318(2):863-71. Epub 2006 May 8.PMID: 16682454 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Hepatic delta9, delta6, and delta5 desaturations in non-insulin-dependent diabetes mellitus eSS rats.

    Montanaro MA, Rimoldi OJ, Igal RA, Montenegro S, Tarrés MC, Martínez SM, Brenner RR.

    Lipids. 2003 Aug;38(8):827-32.PMID: 14577661 [PubMed - indexed for MEDLINE]Related articles

    17.

    Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients.

    Yang WS, Jeng CY, Wu TJ, Tanaka S, Funahashi T, Matsuzawa Y, Wang JP, Chen CL, Tai TY, Chuang LM.

    Diabetes Care. 2002 Feb;25(2):376-80.PMID: 11815513 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Expression and regulation of delta5-desaturase, delta6-desaturase, stearoyl-coenzyme A (CoA) desaturase 1, and stearoyl-CoA desaturase 2 in rat testis.

    Saether T, Tran TN, Rootwelt H, Christophersen BO, Haugen TB.

    Biol Reprod. 2003 Jul;69(1):117-24. Epub 2003 Feb 19.PMID: 12606372 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.

    Sommer M, Wolf G.

    Am J Nephrol. 2007;27(4):425-34. Epub 2007 Jul 3.PMID: 17622750 [PubMed - indexed for MEDLINE]Related articles

    20.

    Altered promoter recycling rates contribute to dominant-negative activity of human peroxisome proliferator-activated receptor-gamma mutations associated with diabetes.

    Li G, Leff T.

    Mol Endocrinol. 2007 Apr;21(4):857-64. Epub 2007 Jan 16.PMID: 17227883 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity